Overview

• Clinicians report a surge of patient questions after President Trump urged women to avoid Tylenol, and they continue to recommend acetaminophen as needed because untreated fever in pregnancy carries documented risks.
• The FDA is initiating label changes to note a possible association with neurodevelopmental outcomes yet states a causal relationship has not been established, with federal communications to providers reflecting that caution.
• European and U.K. regulators, along with the WHO, reiterate that paracetamol remains appropriate in pregnancy and say evidence does not show it causes autism, citing stronger research such as a large Swedish JAMA study finding no causal link.
• Plaintiffs appealing the dismissal of more than 500 Tylenol–autism cases asked the 2nd U.S. Circuit to consider the administration’s stance, while Kenvue points to the FDA’s view that causation is unproven as it defends against the claims.
• Kenvue publicly rejects any causal link and urges patients to consult healthcare providers, and a viral quote purporting to be Tylenol’s response was confirmed by the company and rated by Snopes as fabricated.